Osteoimmunology in bone malignancies: a symphony with evil

Area of Science:

• Osteoimmunology
• Cancer Biology
• Bone Metabolism

Background:

• The bone microenvironment (BME) is crucial for hematopoiesis and immune function.
• Cancerous malignancies frequently compromise the BME, leading to severe complications and mortality.
• Tumor development in the skeletal system triggers complex interactions between cancer, bone, and immune cells, disrupting the BME.

Purpose of the Study:

• To explore the crosstalk between bone metabolism and immune responses in the context of cancer.
• To synthesize current knowledge on the intersection of cancer and osteoimmune biology.
• To provide rationales for emerging immunotherapies targeting bone-related tumors.

Main Methods:

• Literature review synthesizing current knowledge on osteoimmune biology and cancer.
• Analysis of interactions between cancer, bone, and immune cells within the BME.
• Identification of molecular mechanisms driving immunosuppression in bone tumors.

Main Results:

• Bone marrow immune cells can influence tumor progression through interactions with bone cells.
• Specific molecules are identified as responsible for immunosuppression within bone tumors.
• Primary tumors can remotely alter the BME, causing systemic immune suppression.

Conclusions:

• Understanding the intricate relationship between tumor cells and the BME is vital for comprehending bone tumor progression.
• Targeting bone-tumor interactions offers potential for correcting aberrant immune functions.
• Modulating these interactions may inhibit tumor growth and metastasis, improving cancer treatment outcomes.